PRTK — Paratek Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousSmall Cap
- $127.83m
- $343.47m
- $160.27m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -112 | -129 | -96.5 | -59.1 | -63.6 |
Depreciation | |||||
Non-Cash Items | 27.3 | 16.5 | 12.8 | 18.6 | 17.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.92 | -21.7 | -20.3 | -8.19 | -20.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -81.2 | -134 | -103 | -48.3 | -66.1 |
Capital Expenditures | -0.06 | -0.239 | -0.376 | -0.373 | -0.036 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -128 | 135 | 92.9 | 4.88 | 14.8 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -128 | 135 | 92.5 | 4.51 | 14.8 |
Financing Cash Flow Items | — | — | — | — | 0.646 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 221 | 57.6 | 11.3 | 18.3 | 5.09 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 11.7 | 58.1 | 0.415 | -25.4 | -46.2 |